Consumption of drugs for peptic ulcer and related diseases in Spain 2007-2021

The consumption of drugs for peptic ulcer and gastro-oesophageal reflux diseases (gord) in Spain increased by 5.3 dosages per 1,000 inhabitants per day (+4.11%) in 2021 in comparison to the previous year. Therefore, the consumption in Spain reached a peak in 2021 with 134.1 dosages per 1,000 inhabitants per day.
Find more statistics on similiar topics in Spain with key insights such as total value of diuretics pharmaceutical sales and consumption of nonsteroidal anti-inflammatory and antirheumatic products.